Don’t overlook epidemiologic differences

By Howard R. Epps, MD

Proposed algorithm may not apply to other centers

Dr. Kocher and colleagues should be applauded for attempting to help guide empiric antibiotic treatment for acute hematogenous osteomyelitis before culture results become available. The small number of patients with MRSA infections (8 percent) included in this paper, however, makes the applicability of these data to other centers questionable.

This content is only available to members of the AAOS.

Please log in using the link at the top right corner of this page to access your exclusive AAOS member content.

Not a member? Become a member!

Advertisements


Advertisement